- Home
- MNKD vs NFJ Comparison
MNKD vs NFJ Comparison
Compare MNKD & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- NFJ
- Stock Information
- Founded
- MNKD 1991
- NFJ 2005
- Country
- MNKD United States
- NFJ United States
- Employees
- MNKD N/A
- NFJ N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- NFJ Finance: Consumer Services
- Sector
- MNKD Health Care
- NFJ Finance
- Exchange
- MNKD Nasdaq
- NFJ Nasdaq
- Market Cap
- MNKD 1.1B
- NFJ 1.2B
- IPO Year
- MNKD 2004
- NFJ N/A
- Fundamental
- Price
- MNKD $4.06
- NFJ $12.85
- Analyst Decision
- MNKD Buy
- NFJ
- Analyst Count
- MNKD 6
- NFJ 0
- Target Price
- MNKD $9.33
- NFJ N/A
- AVG Volume (30 Days)
- MNKD 3.0M
- NFJ 223.5K
- Earning Date
- MNKD 08-06-2025
- NFJ 01-01-0001
- Dividend Yield
- MNKD N/A
- NFJ 9.01%
- EPS Growth
- MNKD 228.27
- NFJ N/A
- EPS
- MNKD 0.10
- NFJ N/A
- Revenue
- MNKD $297,595,000.00
- NFJ N/A
- Revenue This Year
- MNKD $13.72
- NFJ N/A
- Revenue Next Year
- MNKD $14.94
- NFJ N/A
- P/E Ratio
- MNKD $39.14
- NFJ N/A
- Revenue Growth
- MNKD 32.50
- NFJ N/A
- 52 Week Low
- MNKD $3.51
- NFJ $10.45
- 52 Week High
- MNKD $7.63
- NFJ $12.86
- Technical
- Relative Strength Index (RSI)
- MNKD 55.84
- NFJ 64.33
- Support Level
- MNKD $3.74
- NFJ $12.64
- Resistance Level
- MNKD $4.13
- NFJ $12.83
- Average True Range (ATR)
- MNKD 0.14
- NFJ 0.14
- MACD
- MNKD 0.05
- NFJ 0.01
- Stochastic Oscillator
- MNKD 88.14
- NFJ 92.86
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.